首页 | 本学科首页   官方微博 | 高级检索  
     


Circulating Epstein–Barr virus microRNAs miR‐BART7 and miR‐BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment
Authors:Shaojun Lin  Rob J.A. Verhoeven  Shuang Tong  Yixin Chen  Mingfang Ji  Weimin Cheng  Sai‐Wah Tsao  Maria Lung  Jianji Pan  Honglin Chen
Affiliation:1. Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Provincial Clinical College of Fujian Medical University and Fujian Provincial Key Laboratory of Translational Cancer Medicine (Fujian Provincial Cancer Hospital, Fujian Medical University Union Hospital), Fuzhou, Fujian, People's Republic of China 350014;2. State Key Laboratory for Emerging Infectious Diseases, Department of Microbiology and Research Centre of Infection and Immunology, The University of Hong Kong, Hong Kong SAR, People's Republic of China;3. State Key Laboratory of Molecular Vaccinology & Diagnostics, School of Public Health and National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, People's Republic of China;4. Cancer Research Institute of Zhongshan City, Zhongshan People's Hospital, Zhongshan, Guangdong, People's Republic of China 528403;5. Department of Anatomy, The University of Hong Kong, Hong Kong SAR, People's Republic of China;6. Center for Nasopharyngeal Carcinoma Research, The University of Hong Kong, Hong Kong SAR, People's Republic of China;7. Department of Clinical Oncology, The University of Hong Kong, Hong Kong SAR, People's Republic of China
Abstract:
Keywords:Epstein‐Barr virus  microRNA  NPC  biomarker  EBV BART
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号